ARTICLE | Clinical News
Breast Cancer Index regulatory update
July 28, 2014 7:00 AM UTC
bioMerieux’s bioTheranostics Inc. company said the New York State Department of Health approved the company’s Breast Cancer Index (BCI) to determine the risk of early and late recurrence and benefit f...